Innovation Institutions and the Opioid Crisis
Year of publication: |
2020
|
---|---|
Authors: | Hemel, Daniel Jacob |
Other Persons: | Ouellette, Lisa Larrimore (contributor) |
Publisher: |
[2020]: [S.l.] : SSRN |
Subject: | Innovation | Drogenkonsum | Drug consumption | Institutionelle Infrastruktur | Institutional infrastructure | Arzneimittel | Pharmaceuticals | Institutionenökonomik | Institutional economics |
Extent: | 1 Online-Ressource (62 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Journal of Law and the Biosciences (Forthcoming) Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments February 8, 2020 erstellt |
Classification: | I10 - Health. General ; I11 - Analysis of Health Care Markets ; i13 ; I18 - Government Policy; Regulation; Public Health ; K20 - Regulation and Business Law. General ; K39 - Other Substantive Areas of Law. Other |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Innovation Institutions and COVID-19, Part II
Ouellette, Lisa Larrimore, (2022)
-
Spillover Effects of the Opioid Epidemic on Labor and Innovation
Louca, Christodoulos, (2022)
-
Sauer, Corinne, (2015)
- More ...
-
The Economic Logic of the Lease/Loan Distinction in Bankruptcy
Hemel, Daniel Jacob, (2011)
-
Should Tax Rates Decline with Age?
Hemel, Daniel Jacob, (2011)
-
Comment : Empty Creditors and Debt Exchanges
Hemel, Daniel Jacob, (2011)
- More ...